12 HR ranolazine 500 MG Extended Release Oral Tablet [Ranexa]

RxNorm concept 860738, branded drug (sbd). Prescribable name: Ranexa 500 MG 12HR Extended Release Oral Tablet.

RxCUI: 860738
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/860738 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

ranolazine 35829

Other names

Ranexa 500 MG 12 HR Extended Release Oral Tablet

Related concepts

ranolazine 500 MG (SCDC, consists of)
ranolazine 500 MG [Ranexa] (SBDC, consists of)
Extended Release Oral Tablet (DF, has dose form)
Ranexa (BN, has ingredient)
12 HR ranolazine 500 MG Extended Release Oral Tablet (SCD, tradename of)

Linked data

NDCs

43353088083
61958100102

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 860738 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/860738 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 860738. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.